Literature DB >> 33130583

Maternal complications of fetal triploidy: a case report.

Sarah Wali1, Marianne Wild2.   

Abstract

A 32-year-old woman underwent a medical termination in the second trimester of a spontaneously conceived triploid pregnancy after developing early-onset preeclampsia with subsequent haemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. Placental histology was normal (non-molar) and unusually, she developed ovarian hyperstimulation syndrome (OHSS) 4 weeks later. She was managed conservatively following multidisciplinary team input to exclude malignant pathology. The rarity of late-onset spontaneous OHSS could have resulted in inappropriate surgical management. In the absence of supportive treatment there is also a risk of the condition progressing to a critical stage. Follow-up ultrasonography after termination of pregnancy should be considered for women with evidence of ovarian hyperstimulation, particularly if other risk factors for OHSS are present. Delayed-onset OHSS should be considered in women presenting with bilateral cystic ovarian enlargement after triploid pregnancy. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  abortion; obstetrics and gynaecology; pregnancy; ultrasonography

Year:  2020        PMID: 33130583      PMCID: PMC7783603          DOI: 10.1136/bcr-2020-236950

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Integrating Combined First Trimester Screening for Preeclampsia into Routine Ultrasound Examination.

Authors:  Fabienne Trottmann; Anne Elena Mollet; Sofia Amylidi-Mohr; Daniel Surbek; Luigi Raio; Beatrice Mosimann
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-03-03       Impact factor: 2.915

2.  Selective fetal termination for preeclampsia treatment in a dichorionic gestation with a triploid fetus: A case report.

Authors:  Moti Gulersen; Nidhi Vohra; Clarissa Bonanno
Journal:  Case Rep Womens Health       Date:  2022-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.